CampusDownWiki CampusDown ↗
English

Hypersensitivity Reactions (Four Types)

🩺 Nursing & Health By CampusDown Wiki Editorial Team Last updated
Quick answer: hypersensitivity is an excessive or misdirected immune response that damages the body's own tissues. Gell and Coombs classified it by mechanism into type I (immediate), type II (cytotoxic), type III (immune complex) and type IV (delayed). Types I–III are antibody-mediated; type IV is T-cell-mediated.
Contents
  1. 1. Type I: immediate hypersensitivity
  2. 2. Type II: cytotoxic hypersensitivity
  3. 3. Type III: immune complex hypersensitivity
  4. 4. Type IV: delayed-type hypersensitivity
  5. 5. Study tips
  6. 6. References

Type I: immediate hypersensitivity

IgE made at first exposure (sensitisation) binds to mast cells and basophils. On re-exposure to the same allergen these cells release histamine and other mediators, and symptoms appear within minutes. Examples: allergic rhinitis, asthma, urticaria, food and drug allergy, anaphylaxis. Tests: skin prick test, specific IgE.

Type II: cytotoxic hypersensitivity

IgG or IgM binds antigens on cell surfaces or in tissue and destroys cells or alters their function through complement, phagocytosis or antibody-dependent cytotoxicity. Examples: ABO-incompatible transfusion reactions, haemolytic disease of the newborn, autoimmune haemolytic anaemia, Goodpasture syndrome, Graves' disease (receptor-stimulating). Test: Coombs test.

Type III: immune complex hypersensitivity

Complexes of soluble antigen and antibody deposit in vessel walls, kidney glomeruli or joints, activate complement and cause inflammation. Examples: systemic lupus erythematosus, serum sickness, post-streptococcal glomerulonephritis, the Arthus reaction.

Type IV: delayed-type hypersensitivity

Sensitised T cells, not antibodies, drive the response, which appears 24–72 hours after exposure. Examples: the tuberculin skin test (PPD), contact dermatitis (poison ivy, nickel), part of transplant rejection, type 1 diabetes.

Study tips

  • Remember the mediator: type I IgE, type II antibody against cell-bound antigen, type III immune complexes, type IV T cells.
  • Real diseases can mix mechanisms, and recent textbooks subdivide type IV.
  • For another case of runaway immune activation, see cytokine release syndrome.

References

  1. Gell, P. G. H., & Coombs, R. R. A. (Eds.). (1963). Clinical Aspects of Immunology. Blackwell Scientific.
  2. Abbas, A. K., Lichtman, A. H., & Pillai, S. (2021). Cellular and Molecular Immunology (10th ed.). Elsevier.
  3. Murphy, K., & Weaver, C. (2016). Janeway's Immunobiology (9th ed.). Garland Science.
  4. Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins & Cotran Pathologic Basis of Disease (10th ed.). Elsevier.

Reports and materials that use this theory (Korean)

There are no materials dedicated to this theory yet, but you can search related reports in the CampusDown library (Korean).

Find more reports · Search '면역 과민반응' on CampusDown →

You may also like

This article was last updated on October 15, 2026. It is based on widely recognized original works and textbooks; when citing it in a paper, please check the original sources listed in the references.